An Updated Comparison Between World Health Organization Grade II Gemistocytic and Diffuse Astrocytoma Survival and Treatment Patterns.
Rodrigues A, Zhang M, Toland A, Bhambhvani H, Hayden-Gephart M.
World Neurosurg. 2022 Feb;158:e903-e913. doi: 10.1016/j.wneu.2021.11.089. Epub 2021 Nov 27.
PMID:34844008
Astrocytoma: A Hormone-Sensitive Tumor?
Hirtz A, Rech F, Dubois-Pot-Schneider H, Dumond H.
Int J Mol Sci. 2020 Nov 30;21(23):9114. doi: 10.3390/ijms21239114.
PMID:33266110
Prognostic relevance of gemistocytic grade II astrocytoma: gemistocytic component and MR imaging features compared to non-gemistocytic grade II astrocytoma.
Heo YJ, Park JE, Kim HS, Lee JY, Nam SJ, Jung SC, Choi CG, Kim SJ.
Eur Radiol. 2017 Jul;27(7):3022-3032. doi: 10.1007/s00330-016-4649-z. Epub 2016 Nov 17.
PMID:27858213
Definition and diagnostic implications of gemistocytic astrocytomas: a pathological perspective.